Publications
115
Citations
802
Est. group size
~19
Recurring co-author estimate
Active years
26
Publishing since 2001
Darrion Mitchell's research focuses on head and neck cancers, including squamous cell carcinoma, nasopharyngeal cancer, and thyroid cancer, with an emphasis on radiation therapy, combination treatments with immunotherapy and targeted drugs, and clinical trial design. The work spans laboratory studies of virus-associated cancers, clinical trials testing new drug-radiation combinations, and population-level studies examining treatment disparities and outcomes.
Publication output has grown substantially over the last decade, rising from about 5 papers per year in 2017 to a peak of 23 in 2024, indicating an increasingly active research program.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- A phase 1 study of berzosertib (M6620, VX‐970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)
Cancer · 2026
- Immunotherapy in Initial Treatment of Anaplastic Thyroid Cancer: Evaluation of Overall Survival in a National Cancer Database Study
Thyroid · 2025
- Noncanonical functions of telomerase and telomeres in viruses‐associated cancer
Journal of Medical Virology · 2024
- Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis
The Lancet Oncology · 2024
- Systematic Implementation of Effective Quality Assurance Processes for the Assessment of Radiation Target Volumes in Head and Neck Cancer
Practical Radiation Oncology · 2024
- Staging and Prognosis of Nasopharyngeal Cancer
JAMA Oncology · 2024
- Brachial Plexus Tolerance To Standard Fractionation Re-irradiation
International Journal of Radiation Oncology*Biology*Physics · 2024
- Surrogate Endpoints in p16-Positive Squamous Cell Carcinoma of the Oropharynx
International Journal of Radiation Oncology*Biology*Physics · 2024
- Carotid Blowout after Standard Fractionation Re-irradiation: The Ohio State University Experience
International Journal of Radiation Oncology*Biology*Physics · 2024
- Improving Treatment Plan Robustness at Internal Tissue-Air Interfaces in Head and Neck Radiotherapy
International Journal of Radiation Oncology*Biology*Physics · 2024
- Carotenoid and Nutritional Status During Modern Head and Neck Cancer Therapy
Current Developments in Nutrition · 2024
- 558: Impact of Immunotherapy on Overall Survival in Anaplastic Thyroid Cancer
Radiotherapy and Oncology · 2024
- Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer
Journal for ImmunoTherapy of Cancer · 2023
- Disparities in Survival Outcomes among Racial/Ethnic Minorities with Head and Neck Squamous Cell Cancer in the United States
Cancers · 2023
- Radiotherapy Plus Cisplatin With or Without Lapatinib for Non–Human Papillomavirus Head and Neck Carcinoma
JAMA Oncology · 2023
- International Journal of Radiation Oncology*Biology*Physics×29
- Cancers×8
- Journal of Clinical Oncology×8
- Journal of Medical Virology×5
- Annals of Oncology×5
- Marcelo Bonomi
Medicine · The Ohio State University
- James W. Rocco
Medicine · The Ohio State University
- Priyanka Bhateja
Medicine · The Ohio State University
- Lingbin Meng
Medicine · The Ohio State University
- Tyler Haddad
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile